Lymphatic blood filling in CLEC-2-deficient mouse models.


Journal

Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117

Informations de publication

Date de publication:
03 Apr 2021
Historique:
pubmed: 5 3 2020
medline: 8 10 2021
entrez: 5 3 2020
Statut: ppublish

Résumé

C-type lectin-like receptor 2 (CLEC-2) is considered as a potential drug target in settings of wound healing, inflammation, and infection. A potential barrier to this is evidence that CLEC-2 and its ligand podoplanin play a critical role in preventing lymphatic vessel blood filling in mice throughout life. In this study, this aspect of CLEC-2/podoplanin function is investigated in more detail using new and established mouse models of CLEC-2 and podoplanin deficiency, and models of acute and chronic vascular remodeling. We report that CLEC-2 expression on platelets is not required to maintain a barrier between the blood and lymphatic systems in unchallenged mice, post-development. However, under certain conditions of chronic vascular remodeling, such as during tumorigenesis, deficiency in CLEC-2 can lead to lymphatic vessel blood filling. These data provide a new understanding of the function of CLEC-2 in adult mice and confirm the essential nature of CLEC-2-driven platelet activation in vascular developmental programs. This work expands our understanding of how lymphatic blood filling is prevented by CLEC-2-dependent platelet function and provides a context for the development of safe targeting strategies for CLEC-2 and podoplanin.

Identifiants

pubmed: 32129691
doi: 10.1080/09537104.2020.1734784
pmc: PMC8443399
mid: NIHMS1729675
doi:

Substances chimiques

CLEC-2 protein, mouse 0
Lectins, C-Type 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-367

Subventions

Organisme : British Heart Foundation
ID : CH/03/003/15571
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : British Heart Foundation
ID : RG/13/18/30563
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/13/31673
Pays : United Kingdom

Références

Nat Immunol. 2015 Jan;16(1):75-84
pubmed: 25347465
Blood. 2009 Oct 15;114(16):3464-72
pubmed: 19641185
Am J Respir Cell Mol Biol. 1996 Jun;14(6):577-85
pubmed: 8652186
Development. 2009 Jan;136(2):191-5
pubmed: 19056831
Development. 2018 Feb 8;145(3):
pubmed: 29361560
PLoS One. 2011;6(11):e27385
pubmed: 22110636
Cardiovasc Res. 2001 Feb 16;49(3):507-21
pubmed: 11166264
Trends Immunol. 2005 Jan;26(1):48-55
pubmed: 15629409
Echocardiography. 2017 Sep;34(9):1347-1352
pubmed: 28833533
Blood. 2014 Dec 4;124(24):3656-65
pubmed: 25336627
J Biol Chem. 2012 Jun 22;287(26):22241-52
pubmed: 22556408
Blood. 2007 Feb 15;109(4):1503-6
pubmed: 17032923
Nephrol Dial Transplant. 1999;14 Suppl 1:9-11
pubmed: 10048437
J Biochem. 2011 Aug;150(2):127-32
pubmed: 21693546
Nature. 2014 Oct 23;514(7523):498-502
pubmed: 25341788
J Exp Med. 2015 Nov 16;212(12):2133-46
pubmed: 26552707
Am J Physiol Cell Physiol. 2010 Sep;299(3):C589-605
pubmed: 20519446
Lymphat Res Biol. 2014 Dec;12(4):238-50
pubmed: 25412238
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):108-117
pubmed: 27810998
J Cell Sci. 2006 Nov 1;119(Pt 21):4541-53
pubmed: 17046996
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1016-L1029
pubmed: 28839100
Blood. 2012 Feb 16;119(7):1747-56
pubmed: 22186994
Blood. 2019 Jan 24;133(4):287-288
pubmed: 30679234
Blood. 2011 Jul 21;118(3):723-35
pubmed: 21596846
Dev Cell. 2006 Sep;11(3):349-61
pubmed: 16950126
Curr Med Chem. 2009;16(24):3076-80
pubmed: 19689284
Blood. 2015 Jun 11;125(24):3769-77
pubmed: 25908104
Nature. 2013 Oct 3;502(7469):105-9
pubmed: 23995678
J Clin Invest. 2015 Dec;125(12):4429-46
pubmed: 26571395
Blood. 2015 Jun 25;125(26):4069-77
pubmed: 25795918
J Biol Chem. 2010 Aug 6;285(32):24494-507
pubmed: 20525685
Cell Mol Life Sci. 2019 Feb;76(4):699-728
pubmed: 30377700
Nat Commun. 2017 Feb 10;8:14345
pubmed: 28186091
J Clin Invest. 2013 Feb;123(2):908-16
pubmed: 23348738
Nat Commun. 2017 Dec 21;8(1):2239
pubmed: 29269852
Ann Anat. 2019 Nov;226:73-83
pubmed: 31279869
Arterioscler Thromb Vasc Biol. 2013 May;33(5):926-34
pubmed: 23448972
Haematologica. 2018 Dec;103(12):2097-2108
pubmed: 30026342
Blood. 2010 Jul 29;116(4):661-70
pubmed: 20363774
J Clin Invest. 2019 Jan 2;129(1):12-23
pubmed: 30601137
Semin Cancer Biol. 2019 Dec;59:175-186
pubmed: 31255774
Blood. 2017 Nov 16;130(20):2224-2228
pubmed: 28835437
Science. 2003 Jan 10;299(5604):247-51
pubmed: 12522250
PLoS One. 2012;7(12):e51361
pubmed: 23300543
Cancer Sci. 2018 May;109(5):1292-1299
pubmed: 29575529
Int J Oncol. 2013 Jun;42(6):1849-57
pubmed: 23588876
J Exp Med. 2018 Jan 2;215(1):35-49
pubmed: 29242199
J Clin Invest. 2014 Jan;124(1):273-84
pubmed: 24292710
Haematologica. 2019 Aug;104(8):1648-1660
pubmed: 30733265
Int J Mol Sci. 2019 Feb 06;20(3):
pubmed: 30736372
Blood. 2019 Jan 24;133(4):331-343
pubmed: 30429161
Am J Pathol. 1999 Feb;154(2):385-94
pubmed: 10027397
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13490-13497
pubmed: 31213547
Platelets. 2018 Jun 4;:1-7
pubmed: 29863945
Cancer Cell. 2006 Apr;9(4):261-72
pubmed: 16616332
J Exp Med. 2015 Jul 27;212(8):1255-66
pubmed: 26169941
Am J Pathol. 1997 Oct;151(4):1141-52
pubmed: 9327748
J Thromb Haemost. 2015 Jan;13(1):115-25
pubmed: 25393502
Blood. 2016 Sep 1;128(9):1169-73
pubmed: 27385789
Blood. 2018 Mar 8;131(10):1122-1144
pubmed: 29301754
Angiogenesis. 2014 Jul;17(3):499-509
pubmed: 24668225
Int Rev Cell Mol Biol. 2015;317:185-239
pubmed: 26008786
Nat Commun. 2019 Jan 3;10(1):18
pubmed: 30604758
J Clin Invest. 2008 Nov;118(11):3725-37
pubmed: 18924607
Int J Biochem Cell Biol. 2014 Jan;46:68-75
pubmed: 24275092
Haematologica. 2018 Jun;103(6):e256-e258
pubmed: 29419432
Blood. 2010 May 13;115(19):3997-4005
pubmed: 20110424
Eur J Immunol. 2015 Sep;45(9):2484-93
pubmed: 26173808
Blood. 2019 May 9;133(19):2027-2030
pubmed: 30803989
Cell Mol Life Sci. 2019 May;76(10):1865-1876
pubmed: 30758642
Cell Death Dis. 2018 Jan 25;9(2):115
pubmed: 29371595
J Neurosci Res. 2003 Sep 1;73(5):603-13
pubmed: 12929128

Auteurs

Elizabeth J Haining (EJ)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Kate L Lowe (KL)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Surasak Wichaiyo (S)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.

Raghu P Kataru (RP)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Zoltan Nagy (Z)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Dean Pj Kavanagh (DP)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Sian Lax (S)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Ying Di (Y)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Bernhard Nieswandt (B)

Rudolf Virchow Center for Experimental Biomedicine and Institute of Experimental Biomedicine, University of Würzburg and University Hospital of Würzburg, Würzburg, Germany.

Benoît Ho-Tin-Noé (B)

Institut National de la Santé et de la Recherche Médicale, UMR_S1148, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Bichat, Paris, France.

Babak J Mehrara (BJ)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Yotis A Senis (YA)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Julie Rayes (J)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK.

Steve P Watson (SP)

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH